Role of radiotherapy in ductal (endometrioid) carcinoma of the prostate

Cancer

Volumn 109, Issue 10, 2007, Pages 2011-2015

  Eade, Thomas N ^a   Al Saleem, Tahseen ^a   Horwitz, Eric M ^a   Buyyounouski, Mark K ^a   Chen, David Y T ^a   Pollack, Alan ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Ductal carcinoma; Prosiate cancer; Radiotherapy

Indexed keywords

ANDROGEN;

ACINAR CELL CARCINOMA; AGED; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENDOMETRIOID CARCINOMA; EXTERNAL BEAM RADIOTHERAPY; GLEASON SCORE; HUMAN; MALE; METASTASIS; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; RADIATION DOSE; RETROSPECTIVE STUDY; TREATMENT OUTCOME; UNITED STATES;

AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; CARCINOMA, DUCTAL; COMBINED MODALITY THERAPY; HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE;

EID: 34248388414     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22644     Document Type: Article

References (13)

1. Melicow MM, Pachter MR. Endometrial carcinoma of prostatic utricle (uterus masculinus). Cancer. 1967;20:1715-1722.
2. American Joint Committee on Cancer. Prostate. In: Greene FL, Page DL, Fleming ID, et al., eds. AJCC Cancer Staging Manual. New York: Springer; 2002:337-345.
3. Zaloudek C, Williams JW, Kempson RL. "Endometrial" adenocarcinoma of the prostate: a distinctive tumor of probable prostatic duct origin. Cancer. 1976;37:2255-2262.
4. Bostwick DG, Kindrachuk RW, Rouse RV. Prostatic adenocarcinoma with endometrioid features. Clinical, pathologic, and ultrastructural findings. Am J Surg Pathol. 1985;9:595-609.
5. Epstein JI, Woodruff JM. Adenocarcinoma of the prostate with endometrioid features. A light microscopic and immunohistochemical study of ten cases. Cancer. 1986;57:111-119.
6. Gong Y, Caraway N, Stewart J, et al. Metastatic ductal adenocarcinoma of the prostate: cytologic features and clinical findings. Am J Clin Pathol. 2006;126:302-309.
7. Millar EK, Sharma NK, Lessells AM. Ductal (endometrioid) adenocarcinoma of the prostate: a clinicopathological study of 16 cases. Histopathology. 1996;29:11-19.
8. Oxley JD, Abbott CD, Gillart DA, et al. Ductal carcinomas of the prostate: a clinicopathological and immunohistochemical study. Br J Urol. 1998;81:109-115.
9. Brinker DA, Potter SR, Epstein JI. Ductal adenocarcinoma of the prostate diagnosed on needle biopsy: correlation with clinical and radical prostatectomy findings and progression. Am J Surg Pathol. 1999;23:1471-1479.
10. Christensen WN, Steinberg G, Walsh PC, et al. Prostatic duct adenocarcinoma. Findings at radical prostatectomy. Cancer. 1991;67:2118-2124.
11. Dube VE, Farrow GM, Greene LF. Prostatic adenocarcinoma of ductal origin. Cancer. 1973;32:402-409.
12. Melicow MM, Tannenbaum M. Endometrial carcinoma of uterus masculinus (prostatic utricle). Report of 6 cases. J. Urol. 1971;106:892-902.
13. Tu SM, Reyes A, Maa A, et al. Prostate carcinoma with testicular or penile metastases. Clinical, pathologic, and immunohistochemical features. Cancer. 2002;94:2610-2617.